[KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Abroad (travel likely)RecruitingPHASE3

Conditions

Glaucoma Open-Angle Primary · Ocular Hypertension

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Kukje Pharma, Seongnam, South Korea

    Contact: Study coordinator (Kukje Pharma)